OCX   $0.4  1.06% Market Closed

Oncocyte Corp
Last Events:

2023-03-29 Trend pattern changed from нисходящий клин to нисходящий треугольник.

2023-03-29 Signal in Stochastic changed from bullish to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bullish reversal to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: down-crossing the middle level.

2023-03-29 Signal in EMA20 changed from bullish reversal to bearish reversal. 2023-01-27 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

2023-03-29 Trend changed from down and flat to linear down.

2023-03-29 Trend pattern changed from нисходящий треугольник to нисходящий клин.

2023-03-29 Signal in Stochastic changed from bearish weakening to bullish. The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

2023-03-29 Signal in MACD changed from bearish to bullish reversal. Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: main and signal line crossing.


Current temperature: 1.45
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 0.29
Target: 0.83
High with 50% probability: 0.64
Analyst Recommendations:
Number of estimates 4
Target Price Mean 0.83
Mean unverified/preliminary 0.83 / 0.83
Target Price Low / High 0.40 / 1.40
Median / STD DEV 0.75 / 0.46
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell - Sell
macd Sell Sell Sell
stoch Sell Sell -
ma20 Sell - -
ma50 - Sell -
ma100 Sell - -
Candlestick PatternJan. 9, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US68235C1071
ceo Dr. Michael D. West Ph.D.
Website https://www.oncocyte.com
OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.